title: [Application of Retinalamin for the treatment of glaucomatous optic neuropathy].
abstract: A case of Retinalamin (peptide-based drug) use in a patient with newly diagnosed glaucoma and therapeutically normalized intraocular pressure is reported. The results of visual field test (Humphrey Field Analyzer) and optic nerve examination (Heidelberg Retina Tomograph) as well as electrophysiological indices before and 1 and 3 month after the course of Retinalamin (10 parabulbar injections) are presented.
authors.forename: N V
authors.initials: NV
authors.lastname: Makashova
authors.forename: A E
authors.initials: AE
authors.lastname: Vasil'eva
authors.forename: N E
authors.initials: NE
authors.lastname: Morozova
authors.forename: I A
authors.initials: IA
authors.lastname: Ronzina
mesh_terms: D005074:Evoked Potentials, Visual; D005260:Female; D005902:Glaucoma, Open-Angle / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D056965:Injections, Intraocular; D007429:Intraocular Pressure / Q000187:drug effects; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000008:administration & dosage; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D009900:Optic Nerve / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D009901:Optic Nerve Diseases / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D010455:Peptides / Q000008:administration & dosage*; D041622:Tomography, Optical / Q000379:methods; D016896:Treatment Outcome; D058609:Visual Field Tests / Q000379:methods
chemical_list: D018696:Neuroprotective Agents; D009883:Ophthalmic Solutions; D010455:Peptides; C503555:retinalamin